Medtronic (NYSE:MDT) said today that it launched a clinical trial to evaluate the use of its In.Pact paclitaxel-coated percutaneous transluminal angioplasty balloon catheter in patients with below-the-knee peripheral arterial disease. The company treated its 1st patient in the In.Pact BTK study, performing the procedure on a patient with critical limb ischemia. Get the full story at […]
Medtronic
9 women medtech leaders you need to know
Women account for 50.8% of the U.S. population, yet they only represent 14.8% of all CEOs in the U.S., according to the Center for American Progress. About 78.4% of healthcare industry workers – but only 34.3% of all surgeons and physicians and 15.9% of medical school deans – are women, the center reports. And according to […]
Ethicon goes ahead with Enseal X1 launch
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon is going ahead with the launch of its Enseal X1 instrument, despite an ongoing dispute with its longtime rival in the surgical cutting and sealing market, Medtronic (NYSE:MDT) subsidiary Covidien. “Enseal X1 is the latest example of how Ethicon is advancing technology to give surgeons greater control, access, and accuracy during surgical procedures […]
9 cardiology breakthroughs you need to know
Cardiology breakthroughs couldn’t come soon enough because heart disease is the No. 1 killer of men and women in the U.S. About 610,000 Americans die of heart disease per year, and an additional 735,000 Americans suffer from a heart attack. The statistics terrify. About 610,000 Americans die of heart disease per year, and an additional […]
Medtronic: Certain stent grafts may confuse during implantation
Some Endurant and Endurant II bifurcated stent graft systems could fool doctors into thinking a more serious endoleak is taking place during the implant procedure, causing the doctors to take unnecessary extra interventions, Medtronic is warning in a letter to health providers published in Europe. The voluntary recall announcement, posted today on the website of […]
Elixir Medical’s DeSyne stent tops Medtronic’s Endeavor after 5 years
Elixir Medical‘s novolimus-eluting stent, DeSyne, outperformed Medtronic‘s (NYSE:MDT) zotarolimus-eluting stent, Endeavor, according to long-term data from Elixir’s Excella II trial. The study enrolled 210 patients with 2 or more de novo lesions in 2 different epicardial vessels. Researchers randomly assigned patients in a 2:1 ratio to the novolimus-eluting stent or the zotarolimus-eluting stent. Get the full story at […]
Medtronic touts 5-year economic analysis data from CRT-focused Reverse study
Medtronic (NYSE:MDT) today released 5-year economic analysis data from its Reverse study of patients treated with cardiac resynchronization therapy devices, touting longer lifespans and long-term cost efficiency compared to optimal medical therapy. Results from the Reverse trial were published in the Journal of the American College of Cardiology: Heart Failure. “These new data expand upon […]
Researchers develop 3D-printed, bioabsorbable scaffold for ACL reconstruction
Researchers at the Mayo Clinic‘s tissue engineering and biomaterials laboratory have developed a 3D-printed, porous scaffold for the delayed delivery of recombinant-human bone morphogenetic protein 2, rhBMP-2, to facilitate bone regeneration in patients undergoing ACL reconstruction. The team’s work developing the scaffold and comparing different delivery methods for rhBMP-2 was published this week in Tissue Engineering. […]
Medtronic touts Solitaire stent retriever data
Medtronic (NYSE:MDT) yesterday touted data presented at the International Stroke Conference on its Solitaire stent retriever from 4 studies. The Solitaire stent retriever uses a micro-sized catheter to access arteries in the brain, restoring blood flow and removing blood clots that cause acute ischemic stroke. The Stratis AIS study evaluated the impact of treatment delays and […]
Medtronic lands CE Mark for quad MRI-safe pacers
Medtronic (NYSE:MDT) said today that it won CE Mark approval in the European Union for its line of quadripolar, MRI-safe cardiac resynchronization therapy pacemakers. The approval covers Medtronic’s Percepta, Serena and Solara devices, the Fridley, Minn.-based company said. The devices are slated to the hit the European market in March. “With the addition of quadripolar CRT-P […]
Abbott denies reports it will bail on India’s high-end stent market
Abbott (NYSE:ABT) yesterday denied reports that it’s pulling its high-end coronary stents from India’s market, after the government there put price caps in place for a variety of medical devices and drugs, including stents. India’s National Pharmaceutical Pricing Authority last week issued an order capping the price of stents at about $108 (Rs 7,260) for bare-metal devices […]